Tim Roberts, Chief Commercial Officer of PCI Pharma Services, sat down with Pharma’s Almanac’s Scientific Editor in Chief David Alvaro to discuss the advancements in oncology, the impact the COVID-19 pandemic has had on the industry, and why PCI is well-positioned to be a successful company for years to come.
